Tallac Therapeutics Launches with $62 Million in Series A Financing to Advance Novel Immunotherapies for Cancer
Amount Raised
$62 Million
Round Type
Series A
BurlingameHealthcareDescription
Tallac Therapeutics, Inc., a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer, today announced the completion of its Series A financing totaling $62 million. Tallac is backed by a syndicate of leading global life science venture firms including venBio Partners, Morningside Venture, Lightstone Ventures, Matrix Partners China, and MRL Ventures Fund. The Company plans to use the Series A funding to advance the discovery and development of immunotherapy candidates for multiple solid tumor maligniancies. Its pipeline of next generation immunotherapies are derived from its novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform.
Quick answer
Tallac Therapeutics, Inc. raised $62 Million in a Series A round, dated December 1, 2020. Tallac Therapeutics, Inc. is based in Burlingame, California, United States.
- How much did Tallac Therapeutics, Inc. raise?
- Tallac Therapeutics, Inc. raised $62 Million in a Series A round on December 1, 2020.
- What does Tallac Therapeutics, Inc. do?
- Tallac Therapeutics is a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer.
- Where is Tallac Therapeutics, Inc. based and how big is it?
- Tallac Therapeutics, Inc. is based in Burlingame, California, United States.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Tallac Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Cardio Flow, Inc. raised $489K (Seed) on January 15, 2021.
- Coding Solutions Topco, Inc. raised $41M on January 15, 2021.
- Revolution Global, LLC raised $9.8M on January 15, 2021.
- Emerald Organic Products, Inc. raised an undisclosed amount on January 15, 2021.
- Coding Solutions Topco, Inc. raised $900K (Seed) on January 15, 2021.
- SAGE Therapeutics raised $650M on January 15, 2021.
Who to call at Tallac Therapeutics, Inc., and when
A new round usually means Tallac Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tallac Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tallac Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tallac Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tallac Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansTallac Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.